Radiopharmaceutical trials face extra complexities due to nuclear red tape
The field of radiopharmaceuticals is growing rapidly, with a real buzz in oncology around emerging therapies. Radiopharmaceuticals are drugs that…
Interviews
Build or buy? Key considerations for in-house manufacturing
Clinical trial diversity is a balancing act of time, quality, and money
How can (A)I help? AI chatbot to help understand the world of AI regulation
Sponsors must take on FDA’s diversity guidance to improve community trust
Advancing quality control measures vital for cell and gene therapy development
Mendel.ai software aims to save nurses time in pre-screening
NHS investment critical to drive cell and gene therapy research
